文献速递颅颌面外科

颅面骨纤维异常增殖症的功能结局与复发决定因素:三维计算机断层扫描与综合临床评估的启示

Functional outcomes and recurrence determinants in craniofacial fibrous dysplasia: Insights from 3D computed tomography and comprehensive clinical evaluation.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2024-02-01

回顾性分析2005年7月至2020年12月治疗的47例颅面骨纤维异常增殖症患者,比较保守削除与根治性切除加重建的疗效。根治组在眶异位和面部不对称等功能结局上改善更显著,术后病灶体积更低,但两组病灶增长率相似;年龄≤20岁和多灶性受累是复发的独立危险因素。

要点

  • 根治性切除加重建在眶异位和面部不对称等功能结局上改善更显著。
  • 根治组术后病灶体积低于保守组,但两组病灶增长率无显著差异。
  • 年龄≤20岁和多灶性受累与复发风险升高相关。

核心结论

  • 保守与根治两种治疗对颅面骨纤维异常增殖症均有获益,根治性入路可显著改善功能结局。
  • 两种方法均不能明确减少病灶复发,提示需个体化治疗策略以平衡功能改善与复发风险。

研究设计与样本

  • 回顾性分析47例颅面骨纤维异常增殖症患者,治疗时间为2005年7月至2020年12月。
  • 患者接受保守削除或根治性切除加重建治疗,评估人口学数据、手术细节、病灶复发和功能结局。
  • 通过临床和计算机断层扫描体积分析评估病灶体积变化和复发。

主要发现

  • 16例接受保守治疗,31例接受根治性治疗。
  • 根治组功能结局改善更显著,尤其在眶异位和面部不对称方面。
  • 术后病灶体积根治组为41.94 ± 38.13 cm3,保守组为78.3 ± 47.3 cm3(p = 0.008)。
  • 病灶增长率根治组为8.17 ± 5.85%,保守组为5.84 ± 6.43%(p = 0.268)。
  • 多因素分析显示年龄≤20岁(调整比值比11.269,p = 0.039)和多灶性受累(调整比值比6.914,p = 0.046)与复发风险显著升高相关。

关键数值与推荐

  • 术后病灶体积根治组41.94 ± 38.13 cm3 vs 保守组78.3 ± 47.3 cm3(p = 0.008)。
  • 病灶增长率根治组8.17 ± 5.85% vs 保守组5.84 ± 6.43%(p = 0.268)。
  • 年龄≤20岁复发调整比值比11.269(p = 0.039)。
  • 多灶性受累复发调整比值比6.914(p = 0.046)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aimed to identify risk factors for postoperative lesion regrowth and to assess functional outcomes in craniofacial fibrous dysplasia, using a three-dimensional computed tomographic volumetric analysis. METHODS: A retrospective analysis was conducted on 47 patients with craniofacial fibrous dysplasia who were treated from July 2005 to December 2020. Patients were treated with either conservative shaving or radical excision followed by reconstruction. Demographic data, surgical details, lesion recurrence, and functional outcomes were assessed. Lesion volume changes and recurrence were evaluated clinically and through a computed tomographic volumetric analysis. RESULTS: Among the patients, 16 underwent conservative treatment, whereas 31 received radical treatment. The radical group showed more significant improvements in functional outcomes, particularly in orbital dystopia and facial asymmetry. Postoperative lesion volume was notably lower in the radical group (41.94 ± 38.13 cm3) compared with the conservative group (78.3 ± 47.3 cm3, p = 0.008). This reduction was maintained over an average follow-up of 3 years. Lesion growth rates were similar between the groups (8.17 ± 5.85% in radical vs. 5.84 ± 6.43% in conservative, p = 0.268). Multivariate analysis indicated that patients aged ≤20 years and those with multifocal involvement had significantly higher risks of recurrence, with adjusted odds ratios of 11.269 (p = 0.039) and 6.914 (p = 0.046), respectively. CONCLUSIONS: Our findings suggest that both conservative and radical treatments for craniofacial fibrous dysplasia provide benefits, with the radical approach notably enhancing functional outcomes. However, neither method definitively reduces lesion recurrence, highlighting the necessity for an individualized treatment strategy. This approach should balance functional enhancement with recurrence risks, tailored to each patient's specific clinical scenario.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Kim YC, Han SJ, Choi JW, et al. Functional outcomes and recurrence determinants in craniofacial fibrous dysplasia: Insights from 3D computed tomography and comprehensive clinical evaluation. J Plast Reconstr Aesthet Surg. 2024. PMID: 38489982. doi:10.1016/j.bjps.2024.01.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。